Search Results - Relecom, Allan
- Showing 1 - 5 results of 5
-
1
Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity by Relecom, Allan, Merhi, Maysaloun, Inchakalody, Varghese, Uddin, Shahab, Rinchai, Darawan, Bedognetti, Davide, Dermime, Said
Published 2021Text -
2
-
3
Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy by Raza, Afsheen, Merhi, Maysaloun, Inchakalody, Varghese Philipose, Krishnankutty, Roopesh, Relecom, Allan, Uddin, Shahab, Dermime, Said
Published 2020Text -
4
Resources-Stratified Guidelines for Classical Hodgkin Lymphoma by Relecom, Allan, Federico, Massimo, Connors, Joseph M., Coiffier, Bertrand, Biasoli, Irene, Moccia, Alden, Salles, Gilles, McKee, Thomas, Miralbell, Raymond, Borchmann, Peter, Kuruvilla, John, Johnson, Peter, Cavalli, Franco, Delavy, Martine, Dietrich, Pierre-Yves, Flahault, Antoine
Published 2020Text -
5
Persistent anti-NY-ESO-1-specific T cells and expression of differential biomarkers in a patient with metastatic gastric cancer benefiting from combined radioimmunotherapy treatmen... by Merhi, Maysaloun, Raza, Afsheen, Inchakalody, Varghese Philipose, Siveen, Kodappully S, Kumar, Deepak, Sahir, Fairooz, Mestiri, Sarra, Hydrose, Shereena, Allahverdi, Niloofar, Jalis, Munir, Relecom, Allan, Al Zaidan, Lobna, Hamid, Mohamed Sir Elkhatim, Mostafa, Mai, Gul, Abdul Rehman Zar, Uddin, Shahab, Al Homsi, Mohammed, Dermime, Said
Published 2020Text